Compare MSEX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSEX | CYRX |
|---|---|---|
| Founded | 1897 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 984.5M | 814.9M |
| IPO Year | 1995 | 2008 |
| Metric | MSEX | CYRX |
|---|---|---|
| Price | $52.43 | $17.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $61.00 | $19.33 |
| AVG Volume (30 Days) | 85.4K | ★ 452.6K |
| Earning Date | 10-30-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 1.36 | N/A |
| Revenue | ★ $194,694,000.00 | $176,177,000.00 |
| Revenue This Year | $11.79 | $10.96 |
| Revenue Next Year | $9.17 | $9.97 |
| P/E Ratio | $39.32 | ★ N/A |
| Revenue Growth | ★ 1.47 | N/A |
| 52 Week Low | $44.94 | $7.61 |
| 52 Week High | $62.18 | $17.98 |
| Indicator | MSEX | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.57 | 59.06 |
| Support Level | $49.91 | $14.55 |
| Resistance Level | $52.87 | $17.98 |
| Average True Range (ATR) | 1.02 | 0.51 |
| MACD | -0.31 | 0.03 |
| Stochastic Oscillator | 8.02 | 68.73 |
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.